Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.60
-5.39%
Mkt Cap $623.88M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$4.80
Range $3.70 – $5.70
Implied Upside
+33.5%
Consensus $4.80 vs current $3.60